These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel® in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial. Sirima SB; Durier C; Kara L; Houard S; Gansane A; Loulergue P; Bahuaud M; Benhamouda N; Nebié I; Faber B; Remarque E; Launay O; Vaccine; 2017 Oct; 35(45):6218-6227. PubMed ID: 28947345 [TBL] [Abstract][Full Text] [Related]
11. Assessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infection. Elias SC; Collins KA; Halstead FD; Choudhary P; Bliss CM; Ewer KJ; Sheehy SH; Duncan CJ; Biswas S; Hill AV; Draper SJ J Immunol; 2013 Feb; 190(3):1135-47. PubMed ID: 23293353 [TBL] [Abstract][Full Text] [Related]
12. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response. Kennedy MC; Wang J; Zhang Y; Miles AP; Chitsaz F; Saul A; Long CA; Miller LH; Stowers AW Infect Immun; 2002 Dec; 70(12):6948-60. PubMed ID: 12438374 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys. Pichyangkul S; Tongtawe P; Kum-Arb U; Yongvanitchit K; Gettayacamin M; Hollingdale MR; Limsalakpetch A; Stewart VA; Lanar DE; Dutta S; Angov E; Ware LA; Bergmann-Leitner ES; House B; Voss G; Dubois MC; Cohen JD; Fukuda MM; Heppner DG; Miller RS Vaccine; 2009 Dec; 28(2):452-62. PubMed ID: 19857448 [TBL] [Abstract][Full Text] [Related]
14. Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria. Malkin EM; Diemert DJ; McArthur JH; Perreault JR; Miles AP; Giersing BK; Mullen GE; Orcutt A; Muratova O; Awkal M; Zhou H; Wang J; Stowers A; Long CA; Mahanty S; Miller LH; Saul A; Durbin AP Infect Immun; 2005 Jun; 73(6):3677-85. PubMed ID: 15908397 [TBL] [Abstract][Full Text] [Related]
15. Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein. Sedegah M; Kim Y; Peters B; McGrath S; Ganeshan H; Lejano J; Abot E; Banania G; Belmonte M; Sayo R; Farooq F; Doolan DL; Regis D; Tamminga C; Chuang I; Bruder JT; King CR; Ockenhouse CF; Faber B; Remarque E; Hollingdale MR; Richie TL; Sette A Malar J; 2010 Aug; 9():241. PubMed ID: 20735847 [TBL] [Abstract][Full Text] [Related]
16. Cell-mediated immunity elicited by the blood stage malaria vaccine apical membrane antigen 1 in Malian adults: results of a Phase I randomized trial. Lyke KE; Daou M; Diarra I; Kone A; Kouriba B; Thera MA; Dutta S; Lanar DE; Heppner DG; Doumbo OK; Plowe CV; Sztein MB Vaccine; 2009 Mar; 27(15):2171-6. PubMed ID: 19356621 [TBL] [Abstract][Full Text] [Related]
17. Identification of adjuvants for clinical trials performed with Plasmodium falciparum AMA1 in rabbits. Younis S; Faber BW; Kocken CHM; Remarque EJ BMC Immunol; 2019 Jul; 20(1):25. PubMed ID: 31362695 [TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS,S/AS01B vaccine in rhesus primates. Pichyangkul S; Kum-Arb U; Yongvanitchit K; Limsalakpetch A; Gettayacamin M; Lanar DE; Ware LA; Stewart VA; Heppner DG; Mettens P; Cohen JD; Ballou WR; Fukuda MM Infect Immun; 2008 Jan; 76(1):229-38. PubMed ID: 17954725 [TBL] [Abstract][Full Text] [Related]
19. Plasmodium falciparum-specific cellular immune responses after immunization with the RTS,S/AS02D candidate malaria vaccine in infants living in an area of high endemicity in Mozambique. Barbosa A; Naniche D; Aponte JJ; Manaca MN; Mandomando I; Aide P; Sacarlal J; Renom M; Lafuente S; Ballou WR; Alonso PL Infect Immun; 2009 Oct; 77(10):4502-9. PubMed ID: 19651872 [TBL] [Abstract][Full Text] [Related]
20. Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gamma. Sun P; Schwenk R; White K; Stoute JA; Cohen J; Ballou WR; Voss G; Kester KE; Heppner DG; Krzych U J Immunol; 2003 Dec; 171(12):6961-7. PubMed ID: 14662904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]